{"id":"https://openalex.org/W200766528","doi":null,"title":"[Concomitant therapy with cefmenoxime and cefsulodin for refractory complicated urinary tract infection (especially caused by Pseudomonas aeruginosa)].","display_name":"[Concomitant therapy with cefmenoxime and cefsulodin for refractory complicated urinary tract infection (especially caused by Pseudomonas aeruginosa)].","publication_year":1986,"publication_date":"1986-05-01","ids":{"openalex":"https://openalex.org/W200766528","mag":"200766528","pmid":"https://pubmed.ncbi.nlm.nih.gov/3463188"},"language":"en","primary_location":{"id":"pmid:3463188","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3463188","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hinyokika kiyo. Acta urologica Japonica","raw_type":"English Abstract"},"volume":null,"type":"other","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023249369","display_name":"J Ishigami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Ishigami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111156486","display_name":"A Fujii","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Fujii","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075492732","display_name":"Masuyoshi Harada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Harada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109184386","display_name":"Soichi Arakawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Arakawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018826144","display_name":"Keiichi Umezu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Umezu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073900659","display_name":"Gaku Kawabata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Kawabata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024666570","display_name":"Nobuo Kataoka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Kataoka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109557379","display_name":"Sadao Kamidono","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Kamidono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069864719","display_name":"Shuya Miyazaki","orcid":"https://orcid.org/0009-0009-6494-6675","observed_orcids":["https://orcid.org/0009-0009-6494-6675"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Miyazaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109317666","display_name":"N Takasaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Takasaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"5","first_page":"779","last_page":"88"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.011599999852478504,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefmenoxime","display_name":"cefmenoxime","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cefsulodin","display_name":"cefsulodin","score":1.0},{"id":"https://openalex.org/keywords/complicated-urinary-tract-infection","display_name":"complicated urinary tract infection","score":0.9190000295639038},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9539999961853027},{"id":"https://openalex.org/keywords/refractory-infection","display_name":"refractory infection","score":0.6779999732971191},{"id":"https://openalex.org/keywords/eradication-rate","display_name":"eradication rate","score":0.8029999732971191},{"id":"https://openalex.org/keywords/serratia","display_name":"Serratia","score":0.8159999847412109},{"id":"https://openalex.org/keywords/citrobacter","display_name":"Citrobacter","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gram-negative-bacilli","display_name":"Gram-negative bacilli","score":0.8489999771118164},{"id":"https://openalex.org/keywords/coinfection","display_name":"co-infection","score":0.4189999997615814},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.3889999985694885}],"concepts":[{"id":"https://openalex.org/C2779609581","wikidata":"https://www.wikidata.org/wiki/Q2943815","display_name":"Cefsulodin","level":5,"score":0.7947652339935303},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.7167224884033203},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5976296663284302},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5599934458732605},{"id":"https://openalex.org/C2779617845","wikidata":"https://www.wikidata.org/wiki/Q1563808","display_name":"Superinfection","level":3,"score":0.5228405594825745},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5185635685920715},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4819297790527344},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40892526507377625},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28298214077949524},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.2097444236278534},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.194338858127594},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10770794749259949},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000892","descriptor_name":"Anti-Infective Agents, Urinary","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000892","descriptor_name":"Anti-Infective Agents, Urinary","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000892","descriptor_name":"Anti-Infective Agents, Urinary","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002441","descriptor_name":"Cefsulodin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002441","descriptor_name":"Cefsulodin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002441","descriptor_name":"Cefsulodin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014552","descriptor_name":"Urinary Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014552","descriptor_name":"Urinary Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014552","descriptor_name":"Urinary Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015281","descriptor_name":"Cefmenoxime","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015281","descriptor_name":"Cefmenoxime","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015281","descriptor_name":"Cefmenoxime","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3463188","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3463188","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hinyokika kiyo. Acta urologica Japonica","raw_type":"English Abstract"},{"id":"mag:200766528","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3463188","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":null,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8100000023841858,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2096696443","https://openalex.org/W2106653639","https://openalex.org/W2347367134","https://openalex.org/W12160531","https://openalex.org/W2351342459","https://openalex.org/W2930392229","https://openalex.org/W3208389371","https://openalex.org/W2470410461","https://openalex.org/W2594977116","https://openalex.org/W3015705642"],"abstract_inverted_index":{"Cefmenoxime":[0,182],"(2":[1],"g)":[2,6],"and":[3,59,96,129,137,155,183,219],"cefsulodin":[4,184],"(1":[5],"were":[7,60,132,161,185,244],"given":[8],"twice":[9],"daily":[10],"for":[11,57,62,116,124,144,173,255],"5":[12],"days":[13],"by":[14,32,45,198],"concomitant":[15],"intravenous":[16],"drip":[17],"infusion":[18],"(mixed":[19],"infusion)":[20],"to":[21,41,107,188,195],"135":[22],"patients":[23,189],"with":[24,75,93,190],"complicated":[25,260],"urinary":[26,261],"tract":[27,262],"infection":[28,74],"(c-UTI)":[29],"probably":[30],"caused":[31,197],"Pseudomonas":[33],"aeruginosa.":[34,171,200],"The":[35,78,141,201,222],"clinical":[36],"efficacy":[37,80,204],"was":[38,67,82,113,147,165,177,193,212,231,253],"evaluated":[39],"according":[40],"the":[42,46,55,85,90,99,110,121,156,210,216,256],"criteria":[43,56],"proposed":[44],"UTI":[47],"committee":[48],"in":[49,69,98,179],"Japan.":[50],"Ninety":[51],"one":[52,167],"subjects":[53],"met":[54],"c-UTI":[58,191],"evaluable":[61],"drug":[63],"efficacy.":[64],"P.":[65,94,103,125,170,199],"aeruginosa":[66,95,104],"detected":[68],"44":[70,91],"cases":[71,92,101],"(including":[72],"mixed":[73],"other":[76],"organisms).":[77],"overall":[79,203],"rate":[81,112,123,143,205,224],"73%":[83],"of":[84,89,158,169,206,215,225,258],"91":[86],"cases;":[87],"75%":[88],"70%":[97,208],"47":[100],"without":[102],"infection.":[105,263],"As":[106,172],"bacteriological":[108],"response,":[109],"eradication":[111,122,142,223],"91%":[114],"(105/116)":[115],"all":[117],"cases.":[118,181],"By":[119],"organism,":[120],"aeruginosa,":[126],"Serratia":[127],"spp.":[128,131],"Citrobacter":[130],"82":[133],"(36/44),":[134],"100":[135],"(12/12)":[136],"100%":[138],"(10/10),":[139],"respectively.":[140],"gram-negative":[145],"rods":[146],"93%":[148],"(99/107).":[149],"Twenty-three":[150],"strains":[151],"appeared":[152],"after":[153],"treatment,":[154],"majority":[157],"them":[159],"(13)":[160],"yeast-like":[162],"organisms.":[163],"There":[164],"only":[166],"strain":[168],"side":[174,238],"effects,":[175],"eruption":[176],"found":[178],"2":[180],"administered":[186],"concomitantly":[187],"which":[192],"suspected":[194],"be":[196],"high":[202,227],"about":[207,229],"on":[209],"average":[211],"obtained":[213,232],"regardless":[214],"causative":[217],"organism":[218],"disease":[220],"state.":[221],"as":[226,228],"90%":[230],"excluding":[233],"Enterococcus":[234],"faecalis.":[235],"Neither":[236],"severe":[237],"effects":[239],"nor":[240],"abnormal":[241],"laboratory":[242],"values":[243],"found.":[245],"It":[246],"appeared,":[247],"therefore,":[248],"that":[249],"this":[250],"dosage":[251],"regimen":[252],"useful":[254],"treatment":[257],"refractory":[259]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2016-06-24T00:00:00"}